Axogen (AXGN) FCF Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Axogen | 2.00 Bn | 1.90 Bn | 46.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,284.00 |
| Dec 31, 2025 | 5,398.00 |
| Sep 30, 2025 | -3,828.00 |
| Jun 30, 2025 | 8,864.00 |
| Mar 31, 2025 | 2,067.00 |
| Dec 31, 2024 | 3,166.00 |
| Sep 30, 2024 | 2,080.00 |
| Jun 30, 2024 | 3,150.00 |
| Mar 31, 2024 | 924.00 |
| Dec 31, 2023 | -861.00 |
| Sep 30, 2023 | 4,319.00 |
| Jun 30, 2023 | 2,851.00 |
| Mar 31, 2023 | 396.00 |
| Dec 31, 2022 | -549.00 |
| Sep 30, 2022 | 134.00 |
| Jun 30, 2022 | -1,282.00 |
| Mar 31, 2022 | -1,878.00 |
| Dec 31, 2021 | 299.00 |
| Sep 30, 2021 | 5,172.00 |
| Jun 30, 2021 | 207.00 |
| Mar 31, 2021 | 1,695.00 |
| Dec 31, 2020 | -256.00 |
| Sep 30, 2020 | 8,026.00 |
| Jun 30, 2020 | -1,831.00 |
| Mar 31, 2020 | 256.00 |
| Dec 31, 2019 | 3,955.00 |
| Sep 30, 2019 | 3,309.00 |
| Jun 30, 2019 | 4,096.00 |
| Mar 31, 2019 | 6,649.00 |
| Dec 31, 2018 | 6,140.00 |
| Sep 30, 2018 | 6,178.00 |
| Jun 30, 2018 | 6,723.00 |
| Mar 31, 2018 | 8,899.00 |
| Dec 31, 2017 | 15,646.00 |
| Sep 30, 2017 | 7,737.00 |
| Jun 30, 2017 | 3,364.00 |
| Mar 31, 2017 | 11,855.00 |
| Dec 31, 2016 | 15,399.00 |
| Sep 30, 2016 | 19,027.00 |
| Jun 30, 2016 | 7,908.00 |
| Mar 31, 2016 | 4,137.00 |
| Dec 31, 2015 | 3,520.00 |
| Sep 30, 2015 | 13,467.00 |